T 0733/11 () of 1.2.2013

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2013:T073311.20130201
Date of decision:	01 February 2013
Case number:	T 0733/11
Application number:	03026532.6

T 0732/11 () of 14.4.2016

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2016:T073211.20160414
Date of decision:	14 April 2016
Case number:	T 0732/11
Application number:	07006819.2

T 0725/11 (Combination Antiviral Therapy/GILEAD) of 13.3.2017

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2017:T072511.20170313
Date of decision:	13 March 2017
Case number:	T 0725/11
Application number:	04701819.7

T 0713/11 () of 22.11.2016

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2016:T071311.20161122
Date of decision:	22 November 2016
Case number:	T 0713/11
Application number:	02803337.1

T 0711/11 () of 29.7.2015

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2015:T071111.20150729
Date of decision:	29 July 2015
Case number:	T 0711/11
Application number:	04739158.6

T 0698/11 (Packaging specification/SAP) of 14.12.2011

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2011:T069811.20111214
Date of decision:	14 December 2011
Case number:	T 0698/11
Application number:	05815787.6

T 0690/11 () of 1.3.2016

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2016:T069011.20160301
Date of decision:	01 March 2016
Case number:	T 0690/11
Application number:	03736716.6

T 0664/11 (Oxiranne/SOLVAY) of 25.2.2015

Classe de la CIB :
European Case Law Identifier:	ECLI:EP:BA:2015:T066411.20150225
Date de la décision :	25 Fevrier 2015
Numéro de l'affaire :	T 0664/11
Numéro de la demande :	01967093.4

T 0657/11 () of 8.11.2013

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2013:T065711.20131108
Date of decision:	08 November 2013
Case number:	T 0657/11
Application number:	05747848.9

T 0645/11 () of 26.1.2012

IPC class:
European Case Law Identifier:	ECLI:EP:BA:2012:T064511.20120126
Date of decision:	26 January 2012
Case number:	T 0645/11
Application number:	01912343.9

Pages